Long-term Effects of Endobronchial Valve Implantation on Cardiac Function and Skeletal Muscle Function
NCT05775588
Chronic Disease, Chronic Obstructive Pulmonary Disease
Beijing, Beijing Municipality, China
View Trial DetailsNCT Number: NCT01219946
Chronic obstructive pulmonary disease (COPD) is characterized by a progressive decline in lung function and increased symptoms such as breathlessness/dyspnoea, cough and expectoration.
Even though subjective in nature, the symptomatology of COPD and mainly that of breathlessness/dyspnoea has been studied with the use of objective measurement tools. Taking into consideration that the symptoms experienced by the patient who suffers from a progressive disease such as COPD can only be perceived and interpreted by the patient him- or herself, and thus difficult to be quantified, COPD remains a challenge in clinical research.
Therefore, there is a need to carry out qualitative studies that will provide insight into the wide spectrum of COPD symptomatology from the patient's perspective. In addition, a further mapping of the impact that COPD symptoms' perception has on a patient's life is required, as well as of the different pathways through which symptoms' perception is interpreted regarding the limitations of daily living activities, and the subsequent impact on disease management. The more the physician learns on the embodied experience of COPD, the better he/she may assist the patient in achieving optimal COPD management.
Thus this cross-sectional observational study was designed aiming to obtain these data. Specifically, the study aims to evaluate the most frequently used words by the patients and the physicians to express the symptoms of COPD as well as the limitation of activities that it causes.
Looking for future studies?
Notify Me45 year–75 year
All sexes
Observational
Research Site, Athens, Attica, Greece
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: End of recruitment (estimated timeframe :2.5 months)
Time frame: End of recruitment (estimated timeframe :2.5 months)
Time frame: End of recruitment (estimated timeframe :2.5 months)
Time frame: End of recruitment (estimated timeframe :2.5 months)
Time frame: End of recruitment (estimated timeframe :2.5 months)
Time frame: End of recruitment (estimated timeframe :2.5 months)
Time frame: End of recruitment (estimated timeframe :2.5 months)
Time frame: End of recruitment (estimated timeframe :2.5 months)
Time frame: End of recruitment (estimated timeframe :2.5 months)
Time frame: End of recruitment (estimated timeframe :2.5 months)
Time frame: End of recruitment (estimated timeframe :2.5 months)
Time frame: End of recruitment (estimated timeframe :2.5 months)
Time frame: End of recruitment (estimated timeframe :2.5 months)
Time frame: End of recruitment (estimated timeframe :2.5 months)
Time frame: End of recruitment (estimated timeframe :2.5 months)
Time frame: End of recruitment (estimated timeframe :2.5 months)
Time frame: End of recruitment (estimated timeframe :2.5 months)
Time frame: End of recruitment (estimated timeframe :2.5 months)
Time frame: End of recruitment (estimated timeframe :2.5 months)
Time frame: End of recruitment (estimated timeframe :2.5 months)
Time frame: End of recruitment (estimated timeframe :2.5 months)
AstraZeneca
Industry
A Cross Sectional Study for the Assessment of the Words Used by Patients and Physicians to Express the Symptoms of Chronic Obstructive Pulmonary Disease and the Limitations of Patients' Activities in Primary Care.
Acronym: COPD Language
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05775588
Chronic Disease, Chronic Obstructive Pulmonary Disease
Beijing, Beijing Municipality, China
View Trial DetailsNCT05984823
Chronic Disease, Chronic Obstructive Pulmonary Disease
Leicester, Leicestershire, United Kingdom
View Trial DetailsNCT05572333
COPD, Chronic Disease
Frankfurt, Germany
View Trial DetailsNCT03641235
Chronic Disease, Chronic Obstructive Pulmonary Disease
Bordeaux, France
View Trial Details